- Net profit attributable to UBS Group AG shareholders CHF 707 million; diluted earnings per share CHF 0.18
- Fully applied CET1 capital ratio 14.0%; Swiss SRB fully applied leverage ratio 5.4%
- UBS raises record USD 471 million Oncology Impact Fund to develop cancer treatments
FTSE Mondo Visione Exchanges Index:
.jpg)
UBS's First-Quarter 2016 Results - UBS 1Q Adjusted Profit Before Tax CHF 1.4 Billion
Date 03/05/2016
